SOURCE: BIOLASE Technology, Inc.

August 19, 2008 06:00 ET

BIOLASE Launches Software Upgrade for First Generation Waterlase™ Dental Laser Systems

Part of Long-Term Growth Strategy

IRVINE, CA--(Marketwire - August 19, 2008) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today announced the global launch of a new software upgrade that includes innovations designed to extend the capabilities and useful life of installed first generation Waterlase™ hard and soft tissue dental laser systems. This first-time offering for BIOLASE laser dental products gives these earlier-generation lasers variable pulse repetition rates (frequency) similar to the Company's latest generation Waterlase MD™ and Waterlase® C100 systems, for smoother tissue cutting and increased patient comfort. The Waterlase is used to perform a variety of dental procedures, including cavity preparation, caries removal, tooth etching and a wide range of soft tissue (gum) procedures.

"Offering software upgrades is another part of our overall plan to achieve the highest levels of customer satisfaction and expand our product offerings," said Chief Executive Officer Jake St. Philip. "Extending the useful life of our systems demonstrates our long-term commitment to Waterlase Dentists around the globe, confirms our technological leadership position, and strengthens our long-term opportunities to accelerate our growth." The Company recently reported 13.4 percent growth over the prior year period for the first half of 2008 and has an average 8-year growth rate of over 30 percent. The software upgrade comes one month after the introduction of the new Waterlase C100, which is due to begin shipping at the end of the current quarter.

The software upgrade includes the Waterlase LB 3.0 Operating System which provides five different repetition rates (from 10 to 30Hz) in addition to the original 20 Hz and a new CPU board. The upgrade is being launched this week with the Company's exclusive North American distribution partner Henry Schein Dental, part of Melville, NY-based Henry Schein, Inc. (NASDAQ: HSIC), and installations will start in Waterlase Dentists' offices in September. It is being launched internationally throughout the next few weeks. For software upgrade information, contact BIOLASE Customer Service domestically at 1-800-321-6717 or internationally at 1-949-361-1200.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (, the world's leading dental laser company, develops, manufactures and markets lasers and related products that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, contact:
    David M. Mulder
    Chief Financial Officer of BIOLASE Technology, Inc.


    Jill Bertotti
    Allen & Caron